January 7, 2019
Sumitomo Dainippon Pharma on December 28 corrected its announcement the previous day on the settlement of patent infringement lawsuits over its atypical antipsychotic agent Latuda (lurasidone) in the US. In its previous press release on November 27, announcing the settlement...read more